-
Patent Agency Ranking
公开(公告)号：US09169251B2
公开(公告)日：2015-10-27
申请号：US14316503
申请日：2014-06-26
Applicant: Novartis AG
Inventor： Kamlesh Jagdis Bala , Catherine Leblanc , David Andrew Sandham , Katharine Louise Turner , Simon James Watson , Lyndon Nigel Brown , Brian Cox
IPC: A61K31/437 , A61K45/06 , C07D471/04
CPC classification number: C07D471/04 , A61K31/437 , A61K45/06
Abstract: There are provided according to the invention compounds of formula (I) in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Abstract translation: 根据本发明，提供游离或盐形式的式（I）化合物，其中R 1，R 2，R 3，R 4，R 5，R 6，Q，W，X，m，n和p如说明书中所述， 制备它们的过程，以及它们作为药物的用途。
-
![PYRAZOLO [3,4-D] PYRIMIDINE DERIVATIVES USEFUL TO TREAT RESPIRATORY DISORDERS](/abs-image/US/2018/05/10/US20180125849A1/abs.jpg.150x150.jpg)
公开(公告)号：US20180125849A1
公开(公告)日：2018-05-10
申请号：US15867425
申请日：2018-01-10
Applicant: Novartis AG
Inventor： Graham Charles Bloomfield , Ian Bruce , Brian Cox , Lee Edwards , Judy Fox Hayler , Catherine Howsham
IPC: A61K31/519 , A61K31/5377 , C07D487/04
CPC classification number: A61K31/519 , A61K31/5377 , C07D487/04
Abstract: The present invention concerns a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, where R1-R3 and Y are defined in the description, and its use in the treatment of disorders in which pi3 kinase is implicated.
-
![Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders](/abs-image/US/2014/12/02/US08901134B2/abs.jpg.150x150.jpg)
3.发明授权Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders 有权可用于治疗呼吸系统疾病的吡唑并[3,4-D]嘧啶衍生物公开(公告)号：US08901134B2
公开(公告)日：2014-12-02
申请号：US14261890
申请日：2014-04-25
Applicant: Novartis AG
Inventor： Graham Charles Bloomfield , Ian Bruce , Brian Cox , Lee Edwards , Judy Fox Hayler , Catherine Howsham
IPC: A01N43/90 , A61K31/519 , C07D487/00 , C07D487/04
CPC classification number: A61K31/519 , A61K31/5377 , C07D487/04
Abstract: The present invention concerns a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, where R1-R3 and Y are defined in the description, and its use in the treatment of disorders in which pi3 kinase is implicated.
Abstract translation: 本发明涉及式（I）化合物或其药学上可接受的盐或溶剂合物，其中R1-R3和Y在说明书中定义，及其用于治疗其中涉及pi3激酶的病症。
-
公开(公告)号：US08791256B2
公开(公告)日：2014-07-29
申请号：US13910769
申请日：2013-06-05
Applicant: Novartis AG
Inventor： Kamlesh Jagdis Bala , Catherine Leblanc , David Andrew Sandham , Katharine Louise Turner , Simon James Watson , Lyndon Nigel Brown , Brian Cox
IPC: C07D471/04
CPC classification number: C07D471/04 , A61K31/437 , A61K45/06
Abstract: There are provided according to the invention compounds of formula (I) in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Abstract translation: 根据本发明，提供游离或盐形式的式（I）化合物，其中R 1，R 2，R 3，R 4，R 5，R 6，Q，W，X，m，n和p如说明书中所述， 制备它们的过程，以及它们作为药物的用途。
-
公开(公告)号：US20130267518A1
公开(公告)日：2013-10-10
申请号：US13910769
申请日：2013-06-05
Applicant: Novartis AG
Inventor： Kamlesh Jagdis Bala , Catherine Leblanc , David Andrew Sandham , Katherine Louise Turner , Simon James Watson , Lyndon Nigel Brown , Brian Cox
IPC: C07D471/04
CPC classification number: C07D471/04 , A61K31/437 , A61K45/06
Abstract: There are provided according to the invention compounds of formula (I) in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Abstract translation: 根据本发明，提供游离或盐形式的式（I）化合物，其中R 1，R 2，R 3，R 4，R 5，R 6，Q，W，X，m，n和p如说明书中所述， 制备它们的过程，以及它们作为药物的用途。
-
-
-
-
Search Results
5
records
(took 0.013 seconds)
